{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:23:47Z","timestamp":1787185427970,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16171-3","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:54:56Z","timestamp":1781074496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic significance of therapy-induced senescence and SASP dynamics in acute myeloid leukemia: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Bing","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"12","key":"16171_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377.","journal-title":"Blood"},{"issue":"2","key":"16171_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"H Kantarjian","year":"2021","unstructured":"Kantarjian H, Kadia T. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 2021;11(2):41.","journal-title":"Blood Cancer J"},{"issue":"10","key":"16171_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41408-020-00376-1","volume":"10","author":"N Daver","year":"2020","unstructured":"Daver N, Wei AH, Pollyea DA, Fathi AT, Vyas P. New directions for emerging therapies in acute myeloid leukemia: the next chapter. Blood Cancer J. 2020;10(10):107.","journal-title":"Blood Cancer J"},{"issue":"10","key":"16171_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","volume":"19","author":"CA Schmitt","year":"2022","unstructured":"Schmitt CA, Wang B, Demaria M. Senescence and cancer - role and therapeutic opportunities. Nat Rev Clin Oncol. 2022;19(10):619\u201336.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"16171_CR5","doi-asserted-by":"publisher","first-page":"e3000599","DOI":"10.1371\/journal.pbio.3000599","volume":"18","author":"N Basisty","year":"2020","unstructured":"Basisty N, Kale A. A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol. 2020;18(1):e3000599.","journal-title":"PLoS Biol"},{"issue":"10","key":"16171_CR6","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/jnci\/djab064","volume":"113","author":"PG Prasanna","year":"2021","unstructured":"Prasanna PG, Citrin DE. Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy. J Natl Cancer Inst. 2021;113(10):1285\u201398.","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"16171_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","volume":"19","author":"DV Faget","year":"2019","unstructured":"Faget DV, Ren Q, Stewart SA. Unmasking senescence: context-dependent effects of SASP in cancer. Nat Rev Cancer. 2019;19(8):439\u201353.","journal-title":"Nat Rev Cancer"},{"key":"16171_CR8","doi-asserted-by":"crossref","unstructured":"Cuollo L, Antonangeli F. The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases. Biology (Basel) 2020;9(12):485.","DOI":"10.3390\/biology9120485"},{"issue":"5","key":"16171_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1182\/blood-2018-04-845420","volume":"133","author":"AM Abdul-Aziz","year":"2019","unstructured":"Abdul-Aziz AM, Sun Y, Hellmich C, Marlein CR, Mistry J, Forde E, Piddock RE, Shafat MS, Morfakis A, Mehta T, et al. Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment. Blood. 2019;133(5):446\u201356.","journal-title":"Blood"},{"issue":"13","key":"16171_CR10","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1182\/blood.2019001034","volume":"134","author":"Y Tabe","year":"2019","unstructured":"Tabe Y, Lorenzi PL. Amino acid metabolism in hematologic malignancies and the era of targeted therapy. Blood. 2019;134(13):1014\u201323.","journal-title":"Blood"},{"key":"16171_CR11","doi-asserted-by":"publisher","first-page":"100620","DOI":"10.1016\/j.jbo.2024.100620","volume":"47","author":"AJ Guilatco","year":"2024","unstructured":"Guilatco AJ, Shah MV, Weivoda MM. Senescence in the bone marrow microenvironment: A driver in development of therapy-related myeloid neoplasms. J Bone Oncol. 2024;47:100620.","journal-title":"J Bone Oncol"},{"key":"16171_CR12","doi-asserted-by":"publisher","first-page":"763930","DOI":"10.3389\/fcvm.2021.763930","volume":"8","author":"P Banerjee","year":"2021","unstructured":"Banerjee P, Kotla S, Reddy Velatooru L, Abe RJ, Davis EA, Cooke JP, Schadler K, Deswal A, Herrmann J, Lin SH, et al. Senescence-Associated Secretory Phenotype as a Hinge Between Cardiovascular Diseases and Cancer. Front Cardiovasc Med. 2021;8:763930.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"16171_CR13","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis V, Adams PD, Alimonti A, Bennett DC, Bischof O, Bishop C, Campisi J, Collado M, Evangelou K, Ferbeyre G, et al. Cellular Senescence: Defining a Path Forward. Cell. 2019;179(4):813\u201327.","journal-title":"Cell"},{"issue":"6","key":"16171_CR14","first-page":"344","volume":"60","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2007;60(6):344\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"16171_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.tcb.2022.04.011","volume":"33","author":"RL Cohn","year":"2023","unstructured":"Cohn RL, Gasek NS, Kuchel GA, Xu M. The heterogeneity of cellular senescence: insights at the single-cell level. Trends Cell Biol. 2023;33(1):9\u201317.","journal-title":"Trends Cell Biol"},{"key":"16171_CR16","doi-asserted-by":"crossref","unstructured":"Wyld L, Bellantuono I. Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies. Cancers (Basel) 2020;12(8):2134.","DOI":"10.3390\/cancers12082134"},{"issue":"6","key":"16171_CR17","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang L, Lankhorst L. Exploiting senescence for the treatment of cancer. Nat Rev Cancer. 2022;22(6):340\u201355.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"16171_CR18","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1158\/2159-8290.CD-20-1375","volume":"11","author":"C Duy","year":"2021","unstructured":"Duy C, Li M, Teater M. Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence. Cancer Discov. 2021;11(6):1542\u201361.","journal-title":"Cancer Discov"},{"issue":"2","key":"16171_CR19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.cell.2020.03.008","volume":"181","author":"M Ruscetti","year":"2020","unstructured":"Ruscetti M, Morris JPt, Mezzadra R, Russell J, Leibold J, Romesser PB, Simon J, Kulick A, Ho YJ, Fennell M, et al. Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer. Cell. 2020;181(2):424\u2013e441421.","journal-title":"Cell"},{"issue":"7861","key":"16171_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-021-03547-7","volume":"594","author":"MJ Yousefzadeh","year":"2021","unstructured":"Yousefzadeh MJ, Flores RR, Zhu Y, Schmiechen ZC, Brooks RW, Trussoni CE, Cui Y, Angelini L, Lee KA, McGowan SJ, et al. An aged immune system drives senescence and ageing of solid organs. Nature. 2021;594(7861):100\u20135.","journal-title":"Nature"},{"key":"16171_CR21","first-page":"1","volume":"150","author":"NH Patel","year":"2021","unstructured":"Patel NH, Bloukh S, Alwohosh E, Alhesa A, Saleh T, Gewirtz DA. Autophagy and senescence in cancer therapy. Adv Cancer Res. 2021;150:1\u201374.","journal-title":"Adv Cancer Res"},{"key":"16171_CR22","doi-asserted-by":"crossref","unstructured":"Korbecki J, Kupnicka P. The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML). Cancers (Basel). 2023;15(18):4555.","DOI":"10.3390\/cancers15184555"},{"issue":"4","key":"16171_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1515\/hsz-2020-0196","volume":"402","author":"J Wu","year":"2021","unstructured":"Wu J, Zhang L, Feng Y, Khadka B, Fang Z, Liu J. HDAC8 promotes daunorubicin resistance of human acute myeloid leukemia cells via regulation of IL-6 and IL-8. Biol Chem. 2021;402(4):461\u20138.","journal-title":"Biol Chem"},{"issue":"10","key":"16171_CR24","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/1878-0261.12761","volume":"14","author":"T Saleh","year":"2020","unstructured":"Saleh T, Carpenter VJ, Tyutyunyk-Massey L, Murray G, Leverson JD, Souers AJ, Alotaibi MR, Faber AC, Reed J, Harada H. Clearance of therapy-induced senescent tumor cells by the senolytic ABT-263 via interference with BCL-X(L) -BAX interaction. Mol Oncol. 2020;14(10):2504\u201319.","journal-title":"Mol Oncol"},{"key":"16171_CR25","doi-asserted-by":"crossref","unstructured":"Skelding KA, Barry DL, Theron DZ, Lincz LF. Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia. Int J Mol Sci. 2022;24(1):563.","DOI":"10.3390\/ijms24010563"},{"issue":"7","key":"16171_CR26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2012971","volume":"383","author":"CD DiNardo","year":"2020","unstructured":"DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, Konopleva M, D\u00f6hner H, Letai A, Fenaux P, et al. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia. N Engl J Med. 2020;383(7):617\u201329.","journal-title":"N Engl J Med"},{"key":"16171_CR27","doi-asserted-by":"publisher","first-page":"564108","DOI":"10.3389\/fphar.2020.564108","volume":"11","author":"NN Mohamad Anuar","year":"2020","unstructured":"Mohamad Anuar NN, Nor Hisam NS, Liew SL, Ugusman A. Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent. Front Pharmacol. 2020;11:564108.","journal-title":"Front Pharmacol"},{"issue":"7814","key":"16171_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","volume":"583","author":"C Amor","year":"2020","unstructured":"Amor C, Feucht J, Leibold J, Ho YJ, Zhu C, Alonso-Curbelo D, Mansilla-Soto J, Boyer JA, Li X, Giavridis T. Senolytic CAR T cells reverse senescence-associated pathologies. Nature. 2020;583(7814):127\u201332.","journal-title":"Nature"},{"key":"16171_CR29","doi-asserted-by":"crossref","unstructured":"Prieto LI, Graves SI, Baker DJ. Insights from In Vivo Studies of Cellular Senescence. Cells. 2020;9(4):954.","DOI":"10.3390\/cells9040954"},{"issue":"1","key":"16171_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41232-022-00197-8","volume":"42","author":"N Ohtani","year":"2022","unstructured":"Ohtani N. The roles and mechanisms of senescence-associated secretory phenotype (SASP): can it be controlled by senolysis? Inflamm Regen. 2022;42(1):11.","journal-title":"Inflamm Regen"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16171-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16171-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16171-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:25:16Z","timestamp":1787181916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16171-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16171"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16171-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Institutional Ethics Committee of The First Hospital of Hebei Medical University. Informed consent was obtained from all individual participants included in the study (or their legal guardians) prior to data and sample collection. The study was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1001"}}